Cite

HARVARD Citation

    Pose, A. et al. (2017). Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic‐refractory congestive heart failure: the SEMI‐SEC project. ESC heart failure. pp. 130-137. [Online]. 
  
Back to record